You are subscribed to the Drug Topics Hospital Pharmacists' Report.

Drug Topics Hospital Report

eNewsletter Subscribe

July 15, 2014

Web Version  |  Digital Edition  |  Share with a colleague

Facebook Like   Twitter Tweet

CONTINUING PHARMACY EDUCATION (CPE)

MTM essentials for antiplatelet therapy in cardiovascular disease

This month's article is the sixth in a year-long CPE series, Medication Therapy Management Considerations for Adult Patients with Cardiovascular Disease. From February 2014 through January 2015, pharmacists can earn up to 24 hours of CPE credit with 12 monthly knowledge-based activities from the University of Connecticut School of Pharmacy and Drug Topics.

The goal of this month's activity is to review the pharmacokinetic and pharmacodynamic differences, clinical indications, and pertinent drug-drug interactions for antiplatelet agents in cardiovascular disease.

To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to log in with the session code 14DT08-KTF27.

Drug Topics Hospital Report

Source: Getty Images/Science Photo Library RF

Other Coverage

How long should antiplatelet therapy last after stent implant?

FDA opposes aspirin as primary prevention for stroke

Clot-busting vorapaxar approved

Powered by Modern Medicine Advanstar Medical Communications Group